Caris Life Sciences at ISLB 2026

Nov 7–9, 2026 Madrid, Spain ~700 attendees Website

Caris Life Sciences brings 1 presentation to ISLB 2026 in Madrid, and exhibits at Booth 5. Its work centres on telling apart tumour-derived and blood-cell-derived DNA changes in prostate cancer. One study sequences matched plasma and white blood cell DNA to trace where alterations linked to PARP inhibitors come from, and weighs the clinical impact.

OrganizationISLB 2026 Attendance
carislifesciences.com
Diagnostics & testing labs
Molecular profiling company testing tumor DNA, RNA and proteins, backed by a large molecular and clinical database and AI models.
Booth
Exhibiting at Booth 5
Sat, Nov 710:00am–4:00pm, 6:00–7:30pmSun, Nov 810:00am–4:00pmMon, Nov 98:30am–10:30am
Poster

Explore the full ISLB 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ISLB 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Caris Life Sciences

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the International Society of Liquid Biopsy (ISLB). Submit a correction